Search

Vijay Shankar

Examiner (ID: 12272, Phone: (571)272-7682 , Office: P/2697 )

Most Active Art Unit
2624
Art Unit(s)
2614, 2624, 2673, 2777, 2607, 2629, 2622, 2697, 2778, 2605, 2775, 2787, 2743
Total Applications
2665
Issued Applications
2187
Pending Applications
287
Abandoned Applications
215

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11023734 [patent_doc_number] => 20160220689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'MACROMOLECULES OF DENDRIMER-PLATINUM CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/917915 [patent_app_country] => US [patent_app_date] => 2014-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30961 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917915 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/917915
MACROMOLECULES OF DENDRIMER-PLATINUM CONJUGATES Sep 9, 2014 Abandoned
Array ( [id] => 11277072 [patent_doc_number] => 09493546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Fibronectin based scaffold domain proteins that bind to myostatin' [patent_app_type] => utility [patent_app_number] => 14/481641 [patent_app_country] => US [patent_app_date] => 2014-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 56963 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14481641 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/481641
Fibronectin based scaffold domain proteins that bind to myostatin Sep 8, 2014 Issued
Array ( [id] => 16681721 [patent_doc_number] => 10941187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-09 [patent_title] => GLP-1, exendin-4, peptide analogs and uses thereof [patent_app_type] => utility [patent_app_number] => 14/470528 [patent_app_country] => US [patent_app_date] => 2014-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 45 [patent_no_of_words] => 23996 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14470528 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/470528
GLP-1, exendin-4, peptide analogs and uses thereof Aug 26, 2014 Issued
Array ( [id] => 10997412 [patent_doc_number] => 20160194358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'LINEAR PEPTIDE ANTIBIOTCS' [patent_app_type] => utility [patent_app_number] => 14/911823 [patent_app_country] => US [patent_app_date] => 2014-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 104341 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911823 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/911823
LINEAR PEPTIDE ANTIBIOTCS Aug 13, 2014 Abandoned
Array ( [id] => 16058455 [patent_doc_number] => 10688151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-23 [patent_title] => Peptides having specificity for the lungs [patent_app_type] => utility [patent_app_number] => 14/911197 [patent_app_country] => US [patent_app_date] => 2014-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 10306 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911197 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/911197
Peptides having specificity for the lungs Aug 5, 2014 Issued
Array ( [id] => 10938912 [patent_doc_number] => 20140341934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'PROCESS FOR EXTRACTING MATERIALS FROM BIOLOGICAL MATERIAL' [patent_app_type] => utility [patent_app_number] => 14/451845 [patent_app_country] => US [patent_app_date] => 2014-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2781 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14451845 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/451845
Process for extracting materials from biological material Aug 4, 2014 Issued
Array ( [id] => 10820468 [patent_doc_number] => 20160166632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS' [patent_app_type] => utility [patent_app_number] => 14/905179 [patent_app_country] => US [patent_app_date] => 2014-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22660 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905179 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/905179
PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS Jul 16, 2014 Abandoned
Array ( [id] => 10920375 [patent_doc_number] => 20140323395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'Methods for Treating HCV' [patent_app_type] => utility [patent_app_number] => 14/330495 [patent_app_country] => US [patent_app_date] => 2014-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 60863 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14330495 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/330495
Methods for Treating HCV Jul 13, 2014 Abandoned
Array ( [id] => 10967051 [patent_doc_number] => 20140370082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS' [patent_app_type] => utility [patent_app_number] => 14/324146 [patent_app_country] => US [patent_app_date] => 2014-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25238 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324146 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/324146
CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS Jul 3, 2014 Abandoned
Array ( [id] => 9799537 [patent_doc_number] => 20150011481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'Methods for Treating HCV' [patent_app_type] => utility [patent_app_number] => 14/320843 [patent_app_country] => US [patent_app_date] => 2014-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8429 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14320843 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/320843
Methods for Treating HCV Jun 30, 2014 Abandoned
Array ( [id] => 15227615 [patent_doc_number] => 10501518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-10 [patent_title] => Alpha-/beta-polypeptide analogs of parathyroid hormone (PTH) and method of using same [patent_app_type] => utility [patent_app_number] => 14/312012 [patent_app_country] => US [patent_app_date] => 2014-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 41 [patent_no_of_words] => 13542 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14312012 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/312012
Alpha-/beta-polypeptide analogs of parathyroid hormone (PTH) and method of using same Jun 22, 2014 Issued
Array ( [id] => 10975340 [patent_doc_number] => 20140378375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'ALPHA/BETA-POLYPEPTIDE ANALOGS OF GLUCAGON-LIKE PEPTIDE 1' [patent_app_type] => utility [patent_app_number] => 14/312081 [patent_app_country] => US [patent_app_date] => 2014-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11583 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14312081 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/312081
Alpha/beta-polypeptide analogs of glucagon-like peptide-1 Jun 22, 2014 Issued
Array ( [id] => 10776239 [patent_doc_number] => 20160122394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'FC RECEPTOR (FcRn) BINDING PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/897999 [patent_app_country] => US [patent_app_date] => 2014-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 47726 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897999 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/897999
FC receptor (FcRn) binding peptides and uses thereof Jun 17, 2014 Issued
Array ( [id] => 10912785 [patent_doc_number] => 20140315801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'METHODS OF TREATMENT OF CELL PROLIFERATIVE AND/OR OPHTHALMIC DISEASES, DISORDERS AND CONDITIONS USING INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/308408 [patent_app_country] => US [patent_app_date] => 2014-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 160365 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14308408 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/308408
METHODS OF TREATMENT OF CELL PROLIFERATIVE AND/OR OPHTHALMIC DISEASES, DISORDERS AND CONDITIONS USING INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY Jun 17, 2014 Abandoned
Array ( [id] => 10782921 [patent_doc_number] => 20160129077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-12 [patent_title] => 'Use of recombinant ganoderma immunoregulatory protein (rLZ-8) in preparation of drug for treating melanoma' [patent_app_type] => utility [patent_app_number] => 14/907263 [patent_app_country] => US [patent_app_date] => 2014-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7107 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907263 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/907263
Use of recombinant ganoderma immunoregulatory protein (rLZ-8) in preparation of drug for treating melanoma Jun 12, 2014 Abandoned
Array ( [id] => 10776233 [patent_doc_number] => 20160122389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'PEPTIDES WITH ANTAGONISTIC ACTIVITIES AGAINST NATURAL CXCR4' [patent_app_type] => utility [patent_app_number] => 14/896249 [patent_app_country] => US [patent_app_date] => 2014-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9865 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896249 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/896249
Peptides with antagonistic activities against natural CXCR4 Jun 11, 2014 Issued
Array ( [id] => 14360683 [patent_doc_number] => 10301629 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-28 [patent_title] => Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides [patent_app_type] => utility [patent_app_number] => 14/897450 [patent_app_country] => US [patent_app_date] => 2014-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 25 [patent_no_of_words] => 39069 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897450 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/897450
Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides Jun 10, 2014 Issued
Array ( [id] => 11053371 [patent_doc_number] => 20160250333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'SUBCUTANEOUS INJECTION PREPARATION FOR INDUCING BOVINE SUPEROVULATION' [patent_app_type] => utility [patent_app_number] => 14/907165 [patent_app_country] => US [patent_app_date] => 2014-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4463 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907165 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/907165
Subcutaneous injection product for cattle for inducing superovulation May 22, 2014 Issued
Array ( [id] => 9720934 [patent_doc_number] => 20140256634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'Treatments for Gastrointestinal Disorders' [patent_app_type] => utility [patent_app_number] => 14/286145 [patent_app_country] => US [patent_app_date] => 2014-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16070 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14286145 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/286145
Treatments for Gastrointestinal Disorders May 22, 2014 Abandoned
Array ( [id] => 10729616 [patent_doc_number] => 20160075765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'MODIFIED COLLAGEN MOLECULES' [patent_app_type] => utility [patent_app_number] => 14/890037 [patent_app_country] => US [patent_app_date] => 2014-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 14616 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890037 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/890037
MODIFIED COLLAGEN MOLECULES May 8, 2014 Abandoned
Menu